These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3888854)
1. Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt. Baer J; Harrison R; McAuliffe CA; Zaki A; Sharma HL; Smith AG Int J Appl Radiat Isot; 1985 Mar; 36(3):181-4. PubMed ID: 3888854 [TBL] [Abstract][Full Text] [Related]
2. The synthesis of 191Pt labelled JM216, an orally active platinum anti-tumour agent. Bates PI; Sharma HL; Murrer BA; Bernard CF; McAuliffe CA Appl Radiat Isot; 1997 Apr; 48(4):469-76. PubMed ID: 9106988 [TBL] [Abstract][Full Text] [Related]
3. In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum(II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum(IV), cis-dichloro-bis-cyclopropylamine platinum(II), and cis-diammine 1,1-cyclobutanedicarboxylate platinum(II) in patients with malignant disease, using a gamma camera. Owens SE; Thatcher N; Sharma H; Adam N; Harrison R; Smith A; Zaki A; Baer JC; McAuliffe CA; Crowther D Cancer Chemother Pharmacol; 1985; 14(3):253-7. PubMed ID: 3888431 [TBL] [Abstract][Full Text] [Related]
4. Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cyclopropylamine platinum II, in patients with malignant disease. Thatcher N; Sharma H; Harrison R; Smith A; Zaki A; McAuliffe CA; Crowther D; Fox BW Cancer Chemother Pharmacol; 1982; 9(1):13-6. PubMed ID: 6890414 [TBL] [Abstract][Full Text] [Related]
6. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate. Bierbach U; Sabat M; Farrell N Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108 [TBL] [Abstract][Full Text] [Related]
7. Bispidine analogues of cisplatin, carboplatin, and oxaliplatin. synthesis, structures, and cytotoxicity. Cui H; Goddard R; Pörschke KR; Hamacher A; Kassack MU Inorg Chem; 2014 Apr; 53(7):3371-84. PubMed ID: 24665859 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of the distribution in the male rat of platinum-labelled cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (I), and cis-dichloro-bis-cyclopropylamine platinum (II). Harrison R; McAuliffe CA; Zaki A; Baer J; Sharma H; Smith A; Jackson H; Fox BW Cancer Chemother Pharmacol; 1983; 10(2):90-5. PubMed ID: 6682017 [No Abstract] [Full Text] [Related]
9. Preparation and characterization of platinum(II) and (IV) complexes of 1,3-diaminepropane and 1,4-diaminebutane: circumvention of cisplatin resistance and DNA interstrand cross-link formation in CH1cisR ovarian tumor cells. Alvarez-Valdés A; Pérez JM; López-Solera I; Lannegrand R; Continente JM; Amo-Ochoa P; Camazón MJ; Solans X; Font-Bardía M; Navarro-Ranninger C J Med Chem; 2002 Apr; 45(9):1835-44. PubMed ID: 11960495 [TBL] [Abstract][Full Text] [Related]
10. An autoradiographic study of the intrarenal localisation and retention of cisplatin, iproplatin and paraplatin. Ewen C; Perera A; Hendry JH; McAuliffe CA; Sharma H; Fox BW Cancer Chemother Pharmacol; 1988; 22(3):241-5. PubMed ID: 3044632 [TBL] [Abstract][Full Text] [Related]
15. Effects of the bidentate malonate ligand on the utilization and cytotoxicity of platinum compounds in the L1210 cell line. Mauldin SK; Husain I; Sancar A; Chaney SG Cancer Res; 1986 Jun; 46(6):2876-82. PubMed ID: 3698013 [TBL] [Abstract][Full Text] [Related]
17. Microwave-assisted synthesis of the anticancer drug cisplatin, cis-[Pt(NH3)2Cl2]. Petruzzella E; Chirosca CV; Heidenga CS; Hoeschele JD Dalton Trans; 2015 Feb; 44(7):3384-92. PubMed ID: 25600831 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Structures of 9-Oxabispidine Analogues of Cisplatin, Carboplatin, and Oxaliplatin. Pollak D; Goddard R; Pörschke KR Inorg Chem; 2016 Sep; 55(18):9424-35. PubMed ID: 27603202 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes. Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes. Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]